Effects of APOA5 S19W polymorphism on growth, insulin sensitivity and lipoproteins in normoweight neonates

European Journal of Pediatrics

Volumn 170, Issue 12, 2011, Pages 1551-1558

  Gesteiro, Eva ^a,b   Bastida, Sara ^b   Vázquez Velasco, Miguel ^b   Corella, Dolores ^c   Guillén, Marisa ^c   Ordovas, Jose M ^d   Sánchez Muniz, Francisco J ^b  

^a Hospital de Merida   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c UNIVERSITY OF VALENCIA   (Spain)

^d TUFTS UNIVERSITY   (United States)

Author keywords

Apo A5 gene; Apo B; Appropriate for gestational age; Body weight; HOMA; Insulin resistance markers; Lipids; Newborn; S19W polymorphism

Indexed keywords

APOLIPOPROTEIN A5; APOLIPOPROTEIN B; GLUCOSE; HYDROCORTISONE; INSULIN; LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN;

ADULT; ALLELE; ANTHROPOMETRY; ARTICLE; BIRTH WEIGHT; BODY MASS; BODY WEIGHT; CAUCASIAN; CHILD GROWTH; FEMALE; FETUS GROWTH; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HORMONE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; LIPID BLOOD LEVEL; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; MALE; NEWBORN; PRIORITY JOURNAL;

EID: 85027937501     PISSN: 03406199     EISSN: 14321076     Source Type: Journal    
DOI: 10.1007/s00431-011-1473-y     Document Type: Article

References (43)

1. Álvarez Escolá C, Escrivá Pons F (2008) Influencia de la subnutrición perinatal sobre el desarrollo de las células beta y la acción de la insulina: relación con la diabetes 2 adulta. In: Pascual-Leone AM, Medina JM (eds) Desarrollo perinatal: Origen de patologías adultas. Instituto de España. Real Academia de Farmacia. Monografía XXIII, Madrid, pp 183-185
2. M Aviram M Rosenblat CL Bisgaier, et al. 1998 Paraoxonase inhibits high density lipoproteins oxidation and preserves its functions. A possible peroxidative role for paraoxonase J Clin Invest 101 1581 1590 9541487 10.1172/JCI1649 1:CAS:528:DyaK1cXisV2ru7o%3D (Pubitemid 28198486)
3. S Bastida FJ Sánchez-Muniz C Cuesta, et al. 1997 Male and female cord blood lipoprotein profile differences throughout the term-period J Perinat Med 25 184 191 9189839 10.1515/jpme.1997.25.2.184 1:STN:280:DyaK2szjtlKquw%3D%3D (Pubitemid 27226612)
4. Brandt I (1986) Growth dynamics of low-birth-weight infants with emphasis on the perinatal period. In: Falkner F, Tanner JM (eds) Human growth, vol 1, 2nd edn. Plenum Press, New York, pp 415-475
5. A Canales FJ Sánchez-Muniz 2003 La paraoxonasa, ¿algo más que una enzima? Med Clin (Barc) 121 537 548 10.1157/13053392 (Pubitemid 37429019)
6. GR Chandak KJ Ward CS Yajnik, et al. 2006 Triglyceride associated polymorphisms of the APOA5 gene have very different allele frequencies in Pune, India compared to Europeans BMC Med Genet 10 7 76
7. S Charriere S Bernard M Aqallal, et al. 2008 Association of APOA5 -1131T>C and S19W gene polymorphisms with both mild hypertriglyceridemia and hyperchylomicronemia in type 2 diabetic patients Clin Chim Acta 394 99 103 18468520 10.1016/j.cca.2008.04.013 1:CAS:528:DC%2BD1cXmvFemsL0%3D
8. M Chellakooty K Vangsgaard T Larsen, et al. 2004 A longitudinal study of intrauterine growth and the placental growth hormone (GH)-insulin-like growth factor I axis in maternal circulation: association between placental GH and fetal growth J Clin Endocrinol Metab 89 384 391 14715876 10.1210/jc.2003-030282 1:CAS:528:DC%2BD2cXmvFChtw%3D%3D (Pubitemid 38183908)
9. S Cianfarani D Germani L Rossi, et al. 1998 IGF-I and IGF-binding protein-1 are related to cortisol in human cord blood Eur J Endocrinol 138 524 529 9625363 10.1530/eje.0.1380524 1:CAS:528:DyaK1cXjvFGntbc%3D (Pubitemid 28238187)
10. J Dallongueville D Cottel A Wagner, et al. 2008 The APOA5 Trp19 allele is associated with metabolic syndrome via its association with plasma triglycerides BMC Med Genet 12 9 84
11. F Francés D Corella JV Sorlí, et al. 2005 Validating a rapid method for detecting common polymorphisms in the APOA5 gene by melting curve analysis using LightTyper Clin Chem 51 1279 1282 15976113 10.1373/clinchem.2005.049676 (Pubitemid 43079415)
12. E Gesteiro S Bastida FJ Sánchez-Muniz 2009 Insulin resistance markers in term, normoweight neonates. The Mérida cohort Eur J Pediatr 168 281 288 18597116 10.1007/s00431-008-0750-x 1:CAS:528:DC%2BD1MXhtFelsL4%3D
13. CJ Glueck P Steiner U Leuba 1973 Cord blood low-density lipoprotein-cholesterol estimation versus measurement with the preparative ultracentrifuge J Lab Med 82 467 472 1:CAS:528:DyaE3sXlt1egsL4%3D
14. M Guardiola J Ribalta D Gómez-Coronado, et al. 2010 The apolipoprotein A5 (APOA5) gene predisposes Caucasian children to elevated triglycerides and vitamin E (Four Provinces Study) Atherosclerosis 212 543 547 20688329 10.1016/j.atherosclerosis.2010.07.004 1:CAS:528:DC%2BC3cXht1Ogur7K
15. CN Hales DJ Barker 1992 Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis Diabetologia 5 595 601 10.1007/BF00400248
16. E Herrera MA Lasunción D Gómez-Coronado, et al. 1988 Role of lipoprotein lipase activity on lipoprotein metabolism and the fate of circulating triglycerides in pregnancy Am J Obstet Gynecol 158 1575 1583 3287929 1:CAS:528:DyaL1cXksFagu7s%3D
17. U Hodoglugil S Tanyolac DW Williamson, et al. 2006 Apolipoprotein A-V: a potential modulator of plasma triglyceride levels in Turks J Lipid Res 47 144 153 16258166 10.1194/jlr.M500343-JLR200 1:CAS:528:DC%2BD28XpvVekug%3D%3D (Pubitemid 43107458)
18. T Jannson TL Powell 2007 Role of the placenta in fetal programming: underlying mechanisms and potential interventional approaches Clin Sci (Lond) 113 1 13 10.1042/CS20060339 (Pubitemid 47066020)
19. CQ Lai S Demissie LA Cupples, et al. 2004 Influence of the APOA5 locus on plasma triglyceride, lipoprotein subclasses and CVD risk in the Framingham Heart Study J Lipid Res 45 2096 2105 15342688 10.1194/jlr.M400192-JLR200 1:CAS:528:DC%2BD2cXpsVSktrw%3D (Pubitemid 40990904)
20. CQ Lai ES Tai CE Tan, et al. 2003 The apolipoprotein A5 locus is a strong determinant of plasma triglyceride concentrations across ethnic groups in Singapore J Lipid Res 44 2365 2373 12951359 10.1194/jlr.M300251-JLR200 1:CAS:528:DC%2BD2cXmsVyltw%3D%3D (Pubitemid 38082495)
21. A Lapillone N Peretti PS Ho, et al. 1997 Aetiology, morphology and body composition of infants born small for gestational age Acta Paediatr 423 173 176 (Pubitemid 27511915)
22. L Laviola S Perrini G Belsanti, et al. 2005 Intrauterine growth restriction in humans is associated with abnormalities in placental insulin-like growth factor signalling Endocrinology 146 1498 1505 15564321 10.1210/en.2004-1332 1:CAS:528:DC%2BD2MXitlehtbg%3D (Pubitemid 40289340)
23. B Mackness PN Durrington P McElduff, et al. 2003 Low paraoxonase activity predicts coronary events in the Caerphilly Prospective Study Circulation 107 2775 2779 12756158 10.1161/01.CIR.0000070954.00271.13 1:CAS:528: DC%2BD3sXktFyru7g%3D (Pubitemid 36705985)
24. EM Madsen ML Lindegaard CB Andersen, et al. 2004 Human placenta secretes apolipoprotein B-100-containing lipoproteins J Biol Chem 279 55271 55276 15504742 10.1074/jbc.M411404200 1:CAS:528:DC%2BD2cXhtFeis73O (Pubitemid 40066524)
25. AL Magnusson-Olsson B Hamark A Ericsson 2006 Gestational and hormonal regulation of human placental lipoprotein lipase J Lipid Res 47 2551 2561 16926441 10.1194/jlr.M600098-JLR200 1:CAS:528:DC%2BD28XhtF2rsr7M (Pubitemid 44936116)
26. AL Magnusson IJ Waterman M Wennegren, et al. 2004 Triglyceride hydrolase activities and expression of fatty acid binding proteins in the human placenta in pregnancies complicated by intrauterine growth restriction and diabetes J Clin Endocrinol Metab 89 4607 4614 15356070 10.1210/jc.2003-032234 1:CAS:528:DC%2BD2cXnslWhur4%3D (Pubitemid 39244477)
27. C Marcais B Verges S Charriere, et al. 2005 APOA5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment J Clin Invest 115 2862 2869 16200213 10.1172/JCI24471 1:CAS:528:DC%2BD2MXhtVygt7bK (Pubitemid 41434413)
28. S Martin V Nicaud SE Humphries PJ Talmud 2003 Contribution of APOA5 gene variants to plasma triglyceride determination and to the response to both fat and glucose tolerance challenges Biochim Biophys Acta 1637 217 225 12697303 1:CAS:528:DC%2BD3sXivFCqsbk%3D (Pubitemid 36407772)
29. HC Miller K Hassanein 1971 Diagnosis of impaired fetal growth in newborn infants Pediatrics 48 511 522 5114738 1:STN:280:DyaE38%2FivV2gtQ%3D%3D
30. LS Niculescu J Fruchart-Najib JC Fruchart A Sima 2007 Apolipoprotein A-V gene polymorphisms in subjects with metabolic syndrome Clin Chem Lab Med 45 1133 1139 17635078 10.1515/CCLM.2007.257 1:CAS:528:DC%2BD2sXhtFKjt7vE (Pubitemid 47396269)
31. M Nus FJ Sánchez-Muniz JM Sánchez-Montero 2008 Arilesterasa. Aspectos metodológicos y funcionales en una enzima clave en la enfermedad cardiovascular An R Acad Nac Farm 74 5 27 1:CAS:528: DC%2BD1cXpvVOnurY%3D
32. M Nus FJ Sánchez-Muniz JM Sánchez-Montero 2006 A new method for the determination of arylesterase activity in human serum using simulated body fluid Atherosclerosis 188 155 159 16297389 10.1016/j.atherosclerosis.2005. 10.016 1:CAS:528:DC%2BD28XotV2ntrw%3D (Pubitemid 44142534)
33. M Olivier X Wang R Cole, et al. 2004 Haplotype analysis of the apolipoprotein gene cluster on human chromosome 11 Genomics 83 912 923 15081120 10.1016/j.ygeno.2003.11.016 1:CAS:528:DC%2BD2cXivFGnsrk%3D (Pubitemid 38469930)
34. B Olmedilla-Alonso F Granado-Lorencio C Herrero-Barbudo, et al. 2008 Consumption of restructured meat products with added walnuts has a cholesterol-lowering effect in subjects at high cardiovascular risk: a randomised, crossover, placebo-controlled study J Am Coll Nutr 27 342 348 18689569 1:CAS:528:DC%2BD1cXhtV2htLjN
35. JY Park JK Paik OY Kim, et al. 2010 Interactions between the APOA5 -1131T>C and the FEN1 10154G>T polymorphisms on ω6 polyunsaturated fatty acids in serum phospholipids and coronary artery disease J Lipid Res 51 3881 3888
36. LA Pennacchio M Olivier JA Hubacek, et al. 2002 Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels Hum Mol Genet 11 3031 3038 12417524 10.1093/hmg/11.24.3031 1:CAS:528: DC%2BD38XosFOgs7c%3D (Pubitemid 35414816)
37. R Ross 1999 Atherosclerosis: an inflammatory disease N Engl J Med 340 115 126 9887164 10.1056/NEJM199901143400207 1:STN:280:DyaK1M%2FptFSqtQ%3D%3D (Pubitemid 29054847)
38. FJ Sánchez-Muniz S Bastida S Perea, et al. 1997 Low density lipoprotein in neonates with high cord serum cholesterol levels Acta Paediatr 86 414 418 9174230 10.1111/j.1651-2227.1997.tb09033.x (Pubitemid 27192104)
39. S Setia MG Sridhar V Bhat, et al. 2006 Insulin sensitivity and insulin secretion at birth in intrauterine growth retarded infants Pathology 38 236 238 16753745 10.1080/00313020600696256 1:CAS:528:DC%2BD28XptValsbg%3D (Pubitemid 43879719)
40. PJ Talmud J Palment W Putt, et al. 2005 Determination of the functionality of common APOA5 polymorphisms J Biol Chem 280 28215 28220 15941721 10.1074/jbc.M502144200 1:CAS:528:DC%2BD2MXmvFSgu78%3D (Pubitemid 41105717)
41. JP Thissen JM Ketelslegers LE Underwood 1994 Nutritional regulation of the insulin-like growth factors Endocr Rev 15 80 101 8156941 1:CAS:528:DyaK2cXkvVWmtrw%3D (Pubitemid 24058597)
42. M Tomás M Sentí F García-Faria, et al. 2000 Effect of simvastatin therapy on paraoxonase activity and related lipoproteins in familial hypercholesterolemic patients Atheroscler Thromb Vasc Biol 20 2113 2119 10.1161/01.ATV.20.9.2113
43. Torún B, Chew F (1994) Protein-energy malnutrition. In: Shils ME, Olson JA, Shike M (eds) Modern nutrition in health and disease, 8th edn. Lea & Febiger, Philadelphia, pp 950-976